What question did this study set out to answer?

To explore the reclassification of Ewing sarcoma into distinct molecularly defined subtypes and their implications for diagnosis and treatment.

March 28, 2026

Undifferentiated Small Round Cell Sarcomas: Radiologic-Pathologic Correlation for the Updated WHO Classification Fifth Edition (2020)

Key Result

The WHO 2020 fifth edition reclassified the Ewing sarcoma family into molecularly defined undifferentiated small round cell sarcomas with distinct imaging, pathologic, and molecular features.

Key Points

To explore the reclassification of Ewing sarcoma into distinct molecularly defined subtypes and their implications for diagnosis and treatment.
Review of the World Health Organization 2020 classifications
Analysis of imaging and pathologic features
Discussion of treatment options for each subtype
Identification of distinct imaging characteristics for each subtype
Correlation between pathologic findings and molecular features
Emphasis on the need for radiologist awareness to guide treatment decisions

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

The World Health Organization 2020 fifth edition reclassified the Ewing sarcoma family into molecularly defined undifferentiated small round cell sarcomas, each with distinct imaging, pathologic, and molecular features, underscoring the need for radiologists to understand these subtypes and the treatment options for each.

Bookmark

Cite This Study

Mori et al. (Thu,) reported a other. The WHO 2020 fifth edition reclassified the Ewing sarcoma family into molecularly defined undifferentiated small round cell sarcomas with distinct imaging, pathologic, and molecular features.

synapsesocial.com/papers/69c772818bbfbc51511e3012 https://doi.org/https://doi.org/10.1148/rg.250087